Inhibition of α-secretase (ADAM10) activity reduces the proliferation of stem cell populations, as in neural progenitor cells (NPCs), mesenchymal stem cells (MSC) and human decidua parietalis placenta stem cells (hdPSC [34]), and its levels are significantly reduced in AD patients [35]. Here, ADAM10 is linked to Alzheimer disease.